MSU Drug Discovery

Toggle Accessibility Tools

Welcome to MSU Drug discovery 

NEWS

 

  • "The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer" Moerland et al., Scientific Reports, December 2020

https://www.nature.com/articles/s41598-020-79260-8

  • "Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions" Liu et al., Scientific Reports, October 2020

https://www.nature.com/articles/s41598-020-73680-2

https://doi.org/10.1021/acschembio.8b00849

 

MSU DD Graphic

Upcoming Events

Sparty head logo
Drug Discovery Seminar Series 

Services

ADDRC logo click

  • High throughput screening
  • Automated laboratory robotics
  • Hit selection

InVivo logo click

  • Efficacy testing in normal & disease models
  • Safety testing
  • Imaging
  • In vivo techical assistance
  • PK studies 

MCFpoint

  • Active pharmaceutical ingredient development
  • Screening & target validation
  • Series identification & Scale-up

Other Resources Available:

Molecular Interaction ANalysis

pharmacokinetics

Consultation